Parkinson's disease is a common neurodegenerative disorder characterized by motor symptoms such as bradykinesia, hand tremors, and muscle stiffness. This disease was first described by British doctor James Parkinson in 1817, and with the advancement of medicine, scientists' understanding of Parkinson's disease gradually deepened. Parkinson's disease not only causes great inconvenience to patients' daily lives, but may also lead to various complications, causing long-term impacts on their physical and mental health. This article will delve into the main symptoms, pathogenesis, and common treatment methods of Parkinson's disease, helping people better understand the disease and providing scientific basis for patients to choose appropriate treatment plans.
1、 The main symptoms of Parkinson's disease
1.1 Motor symptoms
1. Resting tremor: Resting tremor is one of the typical symptoms of Parkinson's disease. The patient's hands, feet, or chin involuntarily tremble in a stationary state, usually 4-6 times per second. Hand tremors present a "rolling ball like" motion, where the thumb and index finger repeatedly rub lightly. This tremor decreases or disappears during activity, and intensifies during emotional tension.
2. Slow movement: Slow movement is the core symptom of Parkinson's disease. The patient's movements become slow and sluggish, with difficulty starting or dragging their feet, lacking coordination, and completing simple daily activities such as brushing teeth and dressing may also become difficult. This slow movement is not limited to the limbs, and facial expressions also become stiff, resulting in the so-called 'mask face'.
3. Muscle stiffness: Parkinson's disease patients often exhibit stiff or tense muscles that create resistance during movement. Muscle stiffness is usually bilateral, but it may also start from one side and gradually spread to the other. This muscle stiffness can lead to limited joint movement in patients, further exacerbating motor dysfunction.
4. Unstable posture: Parkinson's disease patients' posture adjustment function gradually weakens, leading to a decrease in balance and a higher risk of falling. When standing or walking, patients may experience tilting forward or backward, which increases the risk of falls in their daily lives.
1.2 Non motor Symptoms
Parkinson's disease not only affects the motor system, but also involves other systems, leading to a range of non motor symptoms. These symptoms may appear in the early or middle stages of the disease and have a significant impact on the patient's quality of life.
1. Reduced sense of smell: In the early stages of the disease, Parkinson's disease patients may experience reduced or even lost sense of smell, which is considered a potential warning signal for Parkinson's disease.
2. Autonomic nervous system dysfunction: Patients with Parkinson's disease may have their autonomic nervous system affected, leading to symptoms such as constipation, urinary incontinence, and sexual dysfunction. Constipation is one of the common non motor symptoms, which seriously affects the digestive function and comfort of patients.
3. Sleep disorders: Many Parkinson's disease patients have sleep problems, including insomnia, daytime sleepiness, and REM Behavior Disorder (RBD). RBD manifests as patients experiencing limb movements and even sleepwalking in their dreams, which has a negative impact on sleep quality.
4. Emotional disorders: Parkinson's disease patients experience significant emotional fluctuations, often accompanied by symptoms of depression and anxiety. This emotional disorder is not only a result of neurological damage, but also a psychological response of patients facing long-term illness.
5. Cognitive impairment: Some Parkinson's disease patients may experience cognitive decline during the course of the disease, manifested as memory loss, lack of concentration, and executive dysfunction, and may even develop dementia.
2、 The pathogenesis of Parkinson's disease
2.1 Dopamine neuron damage
The main pathological feature of Parkinson's disease is the degeneration or death of dopamine neurons in the substantia nigra region of the midbrain, leading to a significant decrease in dopamine levels in the brain. Dopamine is an important neurotransmitter responsible for regulating motor coordination and balance. The decrease in dopamine leads to the imbalance of central motor regulation in the brain, which in turn causes motor symptoms such as hand tremors and delayed movement.
2.2 Lewy body abnormalities
An abnormal protein deposit called Lewy body is often found in the brain cells of Parkinson's disease patients. The main component of the Lewy body is alpha synuclein. In pathological conditions, this protein aggregates into insoluble structures, disrupting the normal function of neurons and ultimately leading to cell death. Louis bodies are not only found in the substantia nigra, but also in other brain regions, which may explain the non motor symptoms of Parkinson's disease.
2.3 Gene Mutations
Research has shown that some Parkinson's disease patients have specific gene mutations, such as mutations in LRRK2, PARK2, PINK1, and other genes, which are closely related to familial Parkinson's disease. These gene mutations can affect the normal metabolic processes of cells, increase the risk of neuronal damage and death, and thus trigger the occurrence of Parkinson's disease.
2.4 Environmental factors
Long term exposure to harmful chemicals such as pesticides and heavy metals may increase the risk of Parkinson's disease. In addition, certain injuries and infections may also be associated with the occurrence of Parkinson's disease. For example, head trauma may cause damage to nerve cells and accelerate the progression of Parkinson's disease.
3、 Treatment options for Parkinson's disease
3.1 Drug therapy
Drug therapy is the most commonly used treatment for Parkinson's disease, with the goal of supplementing dopamine in the brain or regulating dopamine transmission.
1. Levodopa: Levodopa is a dopamine precursor that can be converted into dopamine in the brain and is currently the most effective drug for treating Parkinson's disease. Levodopa can significantly improve motor symptoms, but long-term use may result in side effects such as "end effects" and "dyskinesia".
2. Dopamine receptor agonists: Dopamine receptor agonists such as Pramipexole and Ropiniole can directly stimulate dopamine receptors, reducing the dosage of levodopa. This type of drug has fewer side effects, but its efficacy is slightly inferior to that of levodopa.
3. Monoamine oxidase B inhibitors (MAO-B inhibitors): These drugs can alleviate symptoms of Parkinson's disease by inhibiting dopamine breakdown and increasing dopamine concentration in the brain. MAO-B inhibitors have mild side effects but limited efficacy, and are often used as adjunctive drugs.
3.2 Surgical treatment
For patients with poor drug efficacy, surgical treatment is an option. Common surgical methods include:
1. Deep brain stimulation (DBS): DBS is currently a mature surgical method for Parkinson's disease, which involves implanting electrodes to stimulate specific parts of the brain, inhibit abnormal neural activity, and improve motor symptoms. DBS is effective, but not suitable for all patients and carries surgical risks.
2. Destructive surgery: Destructive surgery improves symptoms by destroying areas in the brain that produce abnormal signals, mainly used to control tremors and slow movement. The effect of this surgery is long-lasting, but irreversible, and it is suitable for a small population.
3.3 Physical therapy and rehabilitation training
Physical therapy is an important means for Parkinson's disease patients to restore motor function. Through specialized rehabilitation training, patients can enhance muscle strength, improve coordination and balance, and reduce the risk of falls. Rehabilitation training includes gait training, balance training, muscle strength training, etc., and can also be combined with physical therapies such as massage and hot compress to alleviate muscle stiffness and pain.
3.4 Other supportive therapies
1. Dietary regulation: Parkinson's disease patients should maintain a balanced diet, supplement protein and vitamins in moderation, and avoid overeating. Dopamine precursor drugs are best taken on an empty stomach to avoid competition with proteins in food and affecting absorption efficiency.
2. Psychological support: Parkinson's disease patients face long-term disease troubles, and psychological support and emotional companionship can help improve their emotions, alleviate anxiety and depression, and improve their quality of life.
Conclusion